Article info

NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin

Authors

  1. Correspondence to Dr Winnie Yeo, Hong Kong, Hong Kong; winnieyeo{at}cuhk.edu.hk
View Full Text

Citation

Yeo W, Lau TK, Kwok CC, et al
NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin

Publication history

  • Received September 17, 2019
  • Revision received December 21, 2019
  • Accepted January 6, 2020
  • First published January 29, 2020.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.